SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advanced Enzyme’s arm inks definitive pact with Evoxx Technologies

27 Jul 2017 Evaluate

Advanced Enzyme Technologies’ wholly owned subsidiary, Advanced Enzymes Europe B.V. based in Amsterdam (Netherlands) has signed a Definitive Agreement on July 26, 2017 with Evoxx Technologies GmbH, a company based in Germany and all the shareholders of Evoxx to acquire 100% shareholding (i.e. 164,031 shares) in Evoxx for a total consideration of Euro 7.65 Million. The acquisition is expected to be completed by mid of August 2017.

On completion of the aforesaid acquisition, Evoxx will become direct subsidiary of Advanced Enzymes Europe B.V. and indirect subsidiary of Advance Enzyme Technologies.

Advanced Enzyme Technologies is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.

Advanced Enzyme Share Price

407.10 49.80 (13.94%)
11-May-2026 11:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1881.70
Dr. Reddys Lab 1288.20
Cipla 1340.70
Zydus Lifesciences 943.75
Lupin 2252.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×